Welcome to F1000 Biology - the expert guide to the most important advances in biology
 New Finding |
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Chi BH, Sinkala M, ..., Safrit JT, Stringer JS Lancet 2007 Nov 17 370 (9600):1698-705 [abstract on PubMed] [related articles] [full text] [order article] |
|||||
|
||||||
"This study shows a novel treatment to reduce HIV drug resistance in HIV-infected..."
To read the rest of this authoritative evaluation by Jonathan Schapiro (AIDS Service, National Hemophilia Center) simply sign-up for a free 3-week trial or take advantage of our special reduced-rate subscription
-
Individuals
Login or Register to get your 3-week trial for instant access to evaluations from over 2000 of the world's top scientists.
Want to continue searching for interesting papers?
-
Recommendations
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
-
Librarians & information managers
Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.
